Mobile laboratories are becoming increasingly important in responses to remote outbreaks. Due to climate change, rising temperatures and spreading arthropod vectors (mosquitoes, ticks), emerging arboviruses (Crimean-Congo haemorrhagic fever virus, West Nile Virus, Rift Valley fever, Dengue Fever,…) are finding their way into Europe and are becoming a major public health concern. Treating only humans whilst neglecting vectors complicates control efforts. Acknowledging the interdependence of environment, human and animal health, a One Health approach is crucial to manage zoonotic outbreaks. To benchmark European mobile laboratory capacity we conducted an inventory: of 193 laboratories, 66% were civilian, 88% exclusively for human diagnostics, and 11% having an accredited quality management system.
To close this diagnostic gap in Europe, MOBILISE will develop a novel quality assured, container-based, mobile One Health laboratory solution. It will receive human/animal/environmental samples for molecular diagnostics, serology, microbiology, and host a One Health whole genome sequencing platform for pathogen discovery and epidemiological analysis. We will further develop novel rapid diagnostic tests, customized to European BSL-3 pathogens, and machine readable from within the BSL-3 glovebox. A novel AI-based “Emergency Operating Centre and decision support system” software will assist end-users in coordinating MOBILISE laboratory fleets across Europe and manage outbreaks in real-time. The laboratory will be field-tested by National agencies and first-responders in Austria, Romania, Greece and Africa to TRL-7. Through smart engineering a major novelty is the green laboratory design on an electric/hybrid truck platform and its energy-efficient workflows and equipment – compliant with the European Green Deal.
